Searched for
LEVONORGESTREL
OTC morning-after pills to be sold in varying doses, with warning: SourcesMorning-after pills will continue to be available without a prescription. However, they will now feature a prominent boxed warning. This wa...- Researchers reveal why drugs aren't tested for people who are obesePrescribed drugs and over-the-counter medications work differently in obese people.
- Study finds common arthritis drug could boost effectiveness of contraceptivesCombining the anti-inflammatory pain medication piroxicam with the widely available morning-after pill levonorgestrel, also called Plan B, ...
- Lupin recalls over 12K cartons of birth control tablets from US marketThe product was manufactured by Lupin Ltd at its Pithampur facility in Madhya Pradesh. The voluntary ongoing nationwide recall is a class I...
- Emergency contraceptive pills to soon be available over-the-counter at chemist stores in IndiaThe move is aimed at allowing women to protect their reproductive rights.
- Glenmark Pharmaceuticals gets two ANDA approvals from USFDAGlenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment inje...
- Sensex gains 200 points, Nifty50 above 7,650; Dish TV down 3%, Hindalco up 1%The S&P BSE Sensex surged over 100 points in early morning trade on Thursday, led by gains in RIL, Infosys, ICICI Bank, L&T, TCS, and SBI.
- Fourteen stocks in focus in Thursday morning tradeThe Indian market is expected to trade in a range. Here is a list of top fourteen stocks that are likely to be in focus today.
- Aurobindo Pharma gets USFDA nod for oral contraceptive tabletsThe product has an estimated market size of $64 million for the twelve months ending October 2015 according to IMS, Aurobindo Pharma said.
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- US court lifts morning-after pill age limitThe FDA had initially decided to approve over-the-counter sales with no age limits, but Sebelius ordered it to reverse course.
- Fifteen stocks in focus in Wednesday morning tradeIndian shares are expected to trade in a range. Here is a list of fifteen stocks that are likely to be in action in morning trade today.
- Lupin gets US nod for 7th oral contraceptiveLupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...
- Lupin gets USFDA nod to market generic contraceptive tabletsDrug firm Lupin today said it has received final approval from the US health regulator to market its generic Levonorgestrel and Ethinyl Est...
- Lupin gets USFDA approval for oral contraceptive tablets KurveloDrug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
- Cipla looking to expand contraceptive pills business; in talks with International Planned ParenthoodThe country's second-largest pharmaceuticals company, Cipla, is in talks with an international health group to expand its contraceptive pil...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
Load More
